Drug Pipe lines
L&J-AD
Alzheimer’s Disease, Protein therapeutics targeting Amyloid-beta and p-Tau
- R&D
- Preclinical
- Phase I
- Phase II
- Phase III
- NDA
L&J-DM
Diabetes Mellitus, Protein therapeutics
- R&D
- Preclinical
- Phase I
- Phase II
- Phase III
- NDA
L&J-AP
Protein therapeutics targeting Alopecia
- R&D
- Preclinical
- Phase I
- Phase II
- Phase III
- NDA
L&J-PA
Protein/Peptide therapeutics targeting chronic pain
- R&D
- Preclinical
- Phase I
- Phase II
- Phase III
- NDA
L&J-PD
Parkinson’s Disease, Protein
- R&D
- Preclinical
- Phase I
- Phase II
- Phase III
- NDA
L&J-HZ
Herpes Zoster, Chemical
- R&D
- Preclinical
- Phase I
- Phase II
- Phase III
- NDA
L&J-EB
Enbrel Biosimilar
- R&D
- Preclinical
- Phase I
- Phase II
- Phase III
- NDA
L&J-HR
Herceptin Biosimilar
- R&D
- Preclinical
- Phase I
- Phase II
- Phase III
- NDA